Champions Oncology OverviewChampions Oncology EBIT
EBIT (Earnings Before Interest and Taxes) analysis for CSBR.
Quarterly EBIT
-$276.00K
↓ 106.11% YoY
As of Jan 31, 2026
Annual EBIT (TTM)
-$2.55M
↓ 137.84% YoY
Trailing 12 months ending Jan 31, 2026
Champions Oncology OverviewEBIT (Earnings Before Interest and Taxes) analysis for CSBR.
As of Jan 31, 2026
Trailing 12 months ending Jan 31, 2026